English | Español

Regulatory
+ Regulatory
Press release submission | Apr 23, 2019

ELI LILLY AND COMPANY: Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
+ Regulatory
Press release submission | Apr 15, 2019

MESOTHELIOMA COMPENSATION CENTER: Now Offers to Make Certain That a Nuclear Power Worker with Mesothelioma or Asbestos Exposure Lung Cancer Gets Accelerated Compensation with The Help of Attorney Erik Karst and His Colleagues at Karst von Oiste
+ Regulatory
Press release submission | Mar 30, 2019

FRESENIUS MEDICAL CARE NORTH AMERICA: Renews Partnership with National Kidney Foundation to Support People Affected by Kidney Disease
+ Regulatory
Press release submission | Mar 15, 2019

CORNERSTONE HEALTHCARE GROUP: Announces Two New Partnerships with Home Health Acquisition and Launch of Long-Term Acute Care Joint Venture Hospital
+ Regulatory
Press release submission | Feb 27, 2019

KAISER PERMANENTE: Improves Emergency Care for Patients With Chest Pain
+ Regulatory
Carrie Salls | Feb 25, 2019

North Carolina citizens express concerns over water, air quality and link to increased incidence of disease due to hog farming
+ Regulatory
Press release submission | Jan 25, 2019

CENTERLINE BIOMEDICAL, INC.: Announces FDA Submission for IOPS System
+ Regulatory
Press release submission | Jan 16, 2019

JANSSEN: Announces European Commission approval of ERLEADA®(apalutamide) for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes